Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP228621.RA8WyK51NOrbt790Y9tW7JgWPT70bM4rr18hJyIoaAWn8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP228621.RA8WyK51NOrbt790Y9tW7JgWPT70bM4rr18hJyIoaAWn8130_assertion type Assertion NP228621.RA8WyK51NOrbt790Y9tW7JgWPT70bM4rr18hJyIoaAWn8130_head.
- NP228621.RA8WyK51NOrbt790Y9tW7JgWPT70bM4rr18hJyIoaAWn8130_assertion description "[The long-term benefits of a finite course of interferon ? (IFN) therapy include a sustained and cumulative response, as well as a reduction in the progression of fibrosis and in the development of cirrhosis and/or HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228621.RA8WyK51NOrbt790Y9tW7JgWPT70bM4rr18hJyIoaAWn8130_provenance.
- NP228621.RA8WyK51NOrbt790Y9tW7JgWPT70bM4rr18hJyIoaAWn8130_assertion evidence source_evidence_literature NP228621.RA8WyK51NOrbt790Y9tW7JgWPT70bM4rr18hJyIoaAWn8130_provenance.
- NP228621.RA8WyK51NOrbt790Y9tW7JgWPT70bM4rr18hJyIoaAWn8130_assertion SIO_000772 23286854 NP228621.RA8WyK51NOrbt790Y9tW7JgWPT70bM4rr18hJyIoaAWn8130_provenance.
- NP228621.RA8WyK51NOrbt790Y9tW7JgWPT70bM4rr18hJyIoaAWn8130_assertion wasDerivedFrom befree-20140225 NP228621.RA8WyK51NOrbt790Y9tW7JgWPT70bM4rr18hJyIoaAWn8130_provenance.
- NP228621.RA8WyK51NOrbt790Y9tW7JgWPT70bM4rr18hJyIoaAWn8130_assertion wasGeneratedBy ECO_0000203 NP228621.RA8WyK51NOrbt790Y9tW7JgWPT70bM4rr18hJyIoaAWn8130_provenance.